Optical Health Related Content

When it comes to children’s spectacles, we ‘must do better’, Dr Alicia Thompson from the Association of British Dispensing Opticians argues.

As we get older, our vision declines and so maintaining our eye health becomes even more important.

Falls cost the UK £4.4 billion per year. Smplicare is on a mission to transform fall prevention and prevent 1 million of those falls by 2030.

Eric Buckland of Translational Imaging Innovations looks at ophthalmic drug development and how better clinical endpoints can improve success rates.

Antonia Chitty, Head of Communications and IT at the Association of British Dispensing Opticians, provides insight into sustainable eyewear and eye care procurement.

Display devices based on quantum dots have promised greater power efficiency, brightness and colour purity than previous generations of displays.

Diabetic retinopathy is the real medical term for diabetic eye disease. It is the most common cause of blindness in people of working age. 94 million people are affected worldwide.

Eric Buckland of Translational Imaging Innovations and Ronald Schuchard, Clinical Product Development Expert, explore the benefits of ophthalmic precision medicine to improve patient care across sectors.

Excessive screen time is linked to obesity, psychological problems and even acceleration of aging - could reducing blue light really slow down the aging process?

Daryl Newsome FBDO R CL SMC(Tech), President of the Association of British Dispensing Opticians, examines the important role that optical practices can play in dealing with eye problems.

Daily, lifelong exposure to blue light which comes from phones, computers and household fixtures can worsen with age.

Translational Imaging Innovations makes data accessible to research degenerative eye disease.

Scientists reveal that a genetic mutation, happening around 10,000 years ago, led to the repression of melanin for humans with blue eyes.

Nick Walsh, updates us on the fast-moving developments in the eye care sector, specifically on the design & manufacture of frames for glasses.

250 million people suffer from visual impairment at a global cost of $3 trillion, Translational Imaging Innovations explain.

Keith Valentine, Chief Executive of Fight for Sight, explains why eye health research needs to be on the political agenda.

First patient-derived stem cell model for studying eye conditions related to oculocutaneous albinism developed by the National Eye Institute Lead author of the report, Doctor Aman George from the National Eye Institute (NEI) stated that “this ‘disease-in-a-dish’ system will help us understand how the absence of pigment in albinism leads...

Professor Sheardown shows C20/20 Innovation Hub at McMaster University leading the way for ophthalmic academic and translational research

European federation Sjögren Europe’s board members emphasise the need for research into this underrepresented and “invisible” condition

New project to allow blind or partially sighted individuals to ‘hear’ the universe is providing a more inclusive side to astronomy This research is offering a way for visually impaired children in particular to get to touch with astronomy and maybe spark a lifetime interest in the topic. What is the...